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Histone deacetylase inhibitors preferentially 
augment transient transgene expression in 
human dermal fibroblasts
Low efficiency of gene transfection has been a major problem 
in gene therapy. Histone deacetylase (HDAC) inhibitors have 
been reported to increase transgene expression in malignant 
cells. Yasukawa et al. report that HDAC inhibitors (FK228, 
cyclic hydroxamic acid-con-
taining peptide 31 and tricho-
statin A) more effectively 
increased transient transgene 
expression in normal human 
dermal fibroblast cells than 
in normal human epidermal 
keratinocyte cells, HaCaT 
cells or stratified cultured epi-
dermal sheets. Nevertheless, 
HDAC inhibitors could not 
satisfactorily reactivate stably 
integrated transgene activ-
ity. HDAC inhibitors may not 
prove so useful for treating 
genetic dermatoses, which 
require cells stably expressing 
the correct gene, but may be 
advantageous in treating non-
healing cutaneous wounds or 
cancer. Br J Dermatol 2007; 
157: 662–9.
Quantitative analysis of Malassezia flora in 
psoriasis
Malassezia species, which constitute a part of the normal skin 
flora, are associated with several skin diseases including pso-
riasis. Takahata et al. 
quantitatively analysed 
Malassezia species in 
the psoriatic scale by 
performing a real-time 
polymerase chain reac-
tion assay, and demon-
strated that colonization 
by M. restricta at various 
body sites was approxi-
mately five times higher 
than that by M. globosa. Furthermore, Malassezia coloniza-
tion was significantly lower in patients with hyperlipidaemia 
than in those with normolipidaemia. This approach may facil-
itate rapid progress in understanding the possible role played 
by Malassezia species in the development of psoriasis. Br J 
Dermatol 2007; 157: 670–3.
Work-related skin disease incidence in the 
U.K. (2002–2005)
U.K. incidence rates for work-related skin disease are deter-
mined through physician-based voluntary surveillance 
schemes such as EPIDERM and OPRA within The Health and 
Occupation Reporting (THOR) network. THOR schemes moni-
tor the burden of work-related dermatoses, and help to target 
interventions. During 2002–2005 the mean annual incidence 
rate of work-related skin disease per million reported by der-
matologists was 91.3 (95% confidence interval 81.8–101.1), 
and by occupa-
tional physicians 
was 316.6 (251.8–
381.3). Most reports 
were of contact der-
matitis, with higher 
incidences found 
in service industries 
(notably hairdress-
ers and beauticians). 
Br J Dermatol 2007; 
157: 713–22.
What predicts severe histological dysplasia/
early melanoma in excised atypical 
melanocytic lesions?
It is frequently difficult to distinguish clinically atypical mela-
nocytic lesions with severe histological atypia or early mela-
noma from those with mild to moderate histological atypia. 
As lesions likely to progress or already progressing to mela-
noma require excision, this distinction is of great importance. 
Strauss et al. retrospectively analysed the clinical character-
istics of excised atypical melanocytic lesions with the aim to 
identify what predicts severe histological atypia/melanoma 
in situ compared with lesions with mild to moderate histo-
logical atypia. Only older age was predictive of severe his-
tological atypia/melanoma in situ, confirming the difficulty 
to differentiate clinically between benign atypical naevi and 
borderline lesions. Br J Dermatol 2007; 157: 758–64.
